In addition, IL-1 was found to mediate the inhibition of estrogen receptor α (ERα) and progesterone receptor (PR) induced by bone marrow stromal cells in ERα+/PR+ BC cells, the upregulation of p62/SQSTM1 and autophagy, and the p62-LC3 interaction. Here, IL1B is linked to breast cancer.